Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析

◆英語タイトル:Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1671
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Active Biotech AB (ACTI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Active Biotech AB (Active Biotech) is a biotechnology company that focuses on the development of therapeutics in the field of cancer, eye disorders and inflammatory/neurodegenerative diseases. The company’s pipeline products in development include Anyara or Naptumomab Estafenatox (naptumomab) for the treatment of solid tumors; tasquinimod for multiple myeloma; and laquinimod for both wetAMD and Uveitis. It has partnership with NeoTX Therapeutics Ltd and with the Perelman School of Medicine, University of Pennsylvania. Active Biotech is headquartered in Lund, Sweden.

Active Biotech AB Key Recent Developments

Apr 23,2020 Active Biotech interim report January – March 2020
Feb 05,2020 Active Biotech announces new direction
Aug 08,2019 Active Biotech: Interim report January – June 2019
May 02,2019 The Election Committee of Active Biotech proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksell to be appointed new member of the Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Active Biotech AB – Key Facts
Active Biotech AB – Key Employees
Active Biotech AB – Key Employee Biographies
Active Biotech AB – Major Products and Services
Active Biotech AB – History
Active Biotech AB – Company Statement
Active Biotech AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Active Biotech AB – Business Description
Active Biotech AB – SWOT Analysis
SWOT Analysis – Overview
Active Biotech AB – Strengths
Active Biotech AB – Weaknesses
Active Biotech AB – Opportunities
Active Biotech AB – Threats
Active Biotech AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Active Biotech AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 23, 2020: Active Biotech interim report January – March 2020
Feb 05, 2020: Active Biotech announces new direction
Aug 08, 2019: Active Biotech: Interim report January – June 2019
May 02, 2019: The Election Committee of Active Biotech proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksell to be appointed new member of the Board
Apr 25, 2019: Active Biotech – Interim report January – March 2019
Feb 14, 2019: Active Biotech year-end report January – December 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Active Biotech AB, Key Facts
Active Biotech AB, Key Employees
Active Biotech AB, Key Employee Biographies
Active Biotech AB, Major Products and Services
Active Biotech AB, History
Active Biotech AB, Other Locations
Active Biotech AB, Subsidiaries
Active Biotech AB, Key Competitors
Active Biotech AB, Ratios based on current share price
Active Biotech AB, Annual Ratios
Active Biotech AB, Annual Ratios (Cont...1)
Active Biotech AB, Interim Ratios
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Active Biotech AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Active Biotech AB, Performance Chart (2015 - 2019)
Active Biotech AB, Ratio Charts
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Active Biotech AB, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Finder Exploration Pty Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Finder Exploration Pty Ltd (Finder) is an oil and gas company that acquires and explores prospective acreage. The company offers acquisition of prospective acreage through drilling and detailed assessment and risk mitigation of exploration acreage. It holds exploration operations in Bedout S …
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Venator Materials PLC (VNTR):企業の財務・戦略的SWOT分析
    Venator Materials PLC (VNTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Drexel University:製薬・医療:M&Aディール及び事業提携情報
    Summary Drexel University (Drexel) is a research university which provides educational degrees and research programs. The university offers courses for undergraduate courses, graduate and professional courses, adult education programs, colleges and schools, libraries and online training services. It …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Chatham Lodging Trust:企業のM&A・事業提携・投資動向
    Chatham Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chatham Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Dynegy Inc:発電所・企業SWOT分析
    Dynegy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • KineMed Inc-医療機器分野:企業M&A・提携分析
    Summary KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs …
  • Ensco plc:企業の戦略・SWOT・財務情報
    Ensco plc - Strategy, SWOT and Corporate Finance Report Summary Ensco plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Biotron Ltd (BIT):製薬・医療:M&Aディール及び事業提携情報
    Summary Biotron Ltd (Biotron) is a clinical stage biotechnology company which researches, develops and commercializes small molecules for the treatment of infectious diseases. Biotron’s core focus is to design and develop drugs that target viral ion channel proteins (viroporins). The company’s lead …
  • The Economist Group Ltd:企業の戦略的SWOT分析
    The Economist Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Bureau Veritas SA:企業の戦略・SWOT・財務分析
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Apollo Global Management Inc:企業の戦略・SWOT・財務分析
    Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report Summary Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CK Hutchison Holdings Ltd:企業のM&A・事業提携・投資動向
    CK Hutchison Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CK Hutchison Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Taisho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products that include lipovitan D, riup, clari …
  • REVA Medical Inc (RVA):製品パイプライン分析
    Summary REVA Medical Inc (REVA) is a medical device company that develops minimally invasive medical devices. The company’s product includes bioresorbable polymers. Its bioresorbable polymers can be applied to a variety of medical applications. REVA’s fantom sirolimus-eluting bioresorbable scaffold …
  • Tokyo Electron Device Ltd.:企業の戦略・SWOT・財務情報
    Tokyo Electron Device Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Device Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tokio Marine Holdings, Inc.:戦略・SWOT・企業財務分析
    Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Foamix Pharmaceuticals Ltd (FOMX):企業の財務・戦略的SWOT分析
    Summary Foamix Pharmaceuticals Ltd (Foamix), formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company’s product candidates include FMX101, a minocycline foam which is intended for the treatment of mod …
  • Vonage Holdings Corp:企業の戦略・SWOT・財務情報
    Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆